You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Beta-adrenergic blocker

Showing 1 - 25 of 4,724
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Behavioral Intervention
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 5, 2022

End-Stage Kidney Disease, End-Stage Renal Disease Trial in Boston, Minneapolis, New York (Metoprolol Succinate, Carvedilol)

Not yet recruiting
  • End-Stage Kidney Disease
  • End-Stage Renal Disease
  • Boston, Massachusetts
  • +4 more
Jun 26, 2023

Coronary Artery Bypass Trial in New Haven (Discontinuing all beta-blocker)

Recruiting
  • Coronary Artery Bypass
  • Discontinuing all beta-blocker
  • New Haven, Connecticut
    Yale New Haven Hospital
Nov 17, 2022

Dilated Cardiomyopathies, Idiopathic, Heart Failure, Systolic, Ventricular Remodeling Trial in Aurora, Columbus (Ivabradine,

Active, not recruiting
  • Dilated Cardiomyopathies, Idiopathic
  • +3 more
  • Aurora, Colorado
  • +1 more
Oct 31, 2022

Atrial Fibrillation, Diastolic Dysfunction, HFpEF - Heart Failure With Preserved Ejection Fraction Trial in Burlington (As

Recruiting
  • Atrial Fibrillation
  • +2 more
  • As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil)
  • Burlington, Vermont
    University of Vermont Medical Center
Feb 28, 2023

Long-term Use of CCB and Breast Cancer Risk

Active, not recruiting
  • Hypertension,Essential
  • Breast Cancer
  • Calcium channel blocker
  • +5 more
  • Bentley, Western Australia, Australia
    Curtin university
Aug 1, 2023

Angina, Stable Ischemic Heart Disease Trial in United States (Clinician Discretion, Beta blocker, Calcium channel blocker)

Not yet recruiting
  • Angina
  • Stable Ischemic Heart Disease
  • Clinician Discretion
  • +2 more
  • Oakland, California
  • +4 more
Mar 23, 2023

Heart Failure, Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction Trial in New York (Beta blocker)

Recruiting
  • Heart Failure
  • +4 more
  • Beta blocker
  • New York, New York
    Weill Cornell Medicine
Jan 31, 2023

Myocardial Infarction Trial in Paris (Beta-blockers withdrawal, Continuation of the Betablockers (ßB) treatment)

Active, not recruiting
  • Myocardial Infarction
  • Beta-blockers withdrawal
  • Continuation of the Betablockers (βB) treatment
  • Paris, France
    Institut de Cardiologie - USIC - Hôpital Pitié-Salpêtrière
Oct 28, 2022

Aortic Valve Stenosis Trial (Beta blocker)

Not yet recruiting
  • Aortic Valve Stenosis
  • Beta blocker
  • (no location specified)
Feb 14, 2023

Healthy Trial in Maastricht (Clenbuterol Hydrochloride, Placebos)

Completed
  • Healthy
  • Clenbuterol Hydrochloride
  • Placebos
  • Maastricht, Limburg, Netherlands
    Maastricht University
Nov 28, 2022

Cirrhosis, Decompensated Cirrhosis, Portal Hypertension Trial (EUS)

Not yet recruiting
  • Cirrhosis
  • +2 more
  • EUS
  • (no location specified)
Nov 13, 2022

Gastric Varices Bleeding, Endoscopic Ultrasound Trial (EUS-Guided Therapy of Glue and Coil, Non-Selective Beta Blockers

Not yet recruiting
  • Gastric Varices Bleeding
  • Endoscopic Ultrasound
  • EUS-Guided Therapy of Glue and Coil
  • Non-Selective Beta Blockers (Propanolol)
  • (no location specified)
May 4, 2023

Alcohol Drinking Trial in New Haven (Propranolol, Placebo)

Recruiting
  • Alcohol Drinking
  • New Haven, Connecticut
    Yale University School of Medicine
Jan 12, 2023

Atrial Fibrillation Trial in Taipei (Reduced dosage of beta-blocker)

Recruiting
  • Atrial Fibrillation
  • Reduced dosage of beta-blocker
  • Taipei, Taiwan
    National Taiwan University Hospital
Apr 19, 2022

Heart Failure With Preserved Ejection Fraction Trial in Farmington (beta blocker discontinuation)

Recruiting
  • Heart Failure With Preserved Ejection Fraction
  • beta blocker discontinuation
  • Farmington, Connecticut
    UConn Health / John Dempsey Hospital
Mar 2, 2022

Tobacco Use Disorder, Nicotine Dependence, Cigarette Smoking Trial in Tulsa (Propranolol, Nicotine Patch, Placebo Propranolol)

Not yet recruiting
  • Tobacco Use Disorder
  • +2 more
  • Tulsa, Oklahoma
    Hardesty Center for Clinical Research and Neuroscience
Oct 18, 2022

REM Sleep Behavior Disorder, Pre-motor Parkinson Disease, Symptomatic Parkinson Disease Trial in Los Angeles (Carvedilol)

Recruiting
  • REM Sleep Behavior Disorder
  • +2 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Aug 23, 2022

Assay to Measure Beta Blocker Adherence

Recruiting
  • Congestive Heart Failure
  • Medication Adherence
  • Quest beta blocker assay
  • Akron, Ohio
    Summa Health System
Mar 4, 2022

Thermogenesis Trial in Basel (Fenoterol, Mild cold exposure)

Recruiting
  • Thermogenesis
  • Basel, Switzerland
    University Hospital Basel, Dept. of Endocrinology
Apr 27, 2022

Atrial Fibrillation, Left Atrial Rhythm Trial in Monastir (Digoxin 0.25 mg, Bisoprolol)

Recruiting
  • Atrial Fibrillation
  • Left Atrial Rhythm
  • Monastir, Tunisia
    Fattouma Bourguiba University hospital
Sep 14, 2022

Advanced Melanoma Trial in New Brunswick (Propranolol, Naltrexone)

Not yet recruiting
  • Advanced Melanoma
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jul 18, 2023

Acute Coronary Syndrome Trial in Naples (Carvedilol, Metoprolol)

Completed
  • Acute Coronary Syndrome
  • Naples, Italy
    Federico II University of Naples
Mar 15, 2022

Myocardial Infarction Trial in Seoul (Discontinuation of ß-blocker)

Recruiting
  • Myocardial Infarction
  • Discontinuation of β-blocker
  • Seoul, Korea, Republic of
    Samsung Medical Center
May 8, 2022

Tetralogy of Fallot Trial in Pittsburgh (other, procedure, drug)

Not yet recruiting
  • Tetralogy of Fallot
  • N-thymidine
  • +7 more
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Jul 5, 2022